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Abstract: Dendritic cells’ (DCs) ability to present antigens and initiate the adaptive immune response
confers them a pivotal role in immunological defense against hostile infection and, at the same
time, immunological tolerance towards harmless components of the microbiota. Food products
can modulate the inflammatory status of intestinal DCs. Among nutritionally-derived products,
we investigated the ability of quercetin to suppress inflammatory cytokines secretion, antigen
presentation, and DCs migration towards the draining lymph nodes. We recently identified the
Slpi expression as a crucial checkpoint required for the quercetin-induced inflammatory suppression.
Here we demonstrate that Slpi-KO DCs secrete a unique panel of cytokines and chemokines following
quercetin exposure. In vivo, quercetin-enriched food is able to induce Slpi expression in the ileum,
while little effects are detectable in the duodenum. Furthermore, Slpi expressing cells are more
frequent at the tip compared to the base of the intestinal villi, suggesting that quercetin exposure
could be more efficient for DCs projecting periscopes in the intestinal lumen. These data suggest that
quercetin-enriched nutritional regimes may be efficient for suppressing inflammatory syndromes
affecting the ileo-colonic tract.
Keywords: quercetin; dendritic cells; Slpi; inflammation
1. Introduction
Quercetin is among the best known phytochemicals able to impact different aspects of human
health [1]. Quercetin also has anti-oxidant [2,3] anti-proliferative [4–6] and anti-inflammatory
properties [7–9]. We recently demonstrated that murine dendritic cells, previously exposed to quercetin,
suppress inflammatory pathways induced by LPS administration [10–12].
Nutrients 2017, 9, 706; doi:10.3390/nu9070706 www.mdpi.com/journal/nutrients
Nutrients 2017, 9, 706 2 of 11
Dendritic cells (DCs) are the most powerful antigen presenting cells and are able to capture
antigens, migrate to the draining lymph node and present them to initiate the adaptive immune
response [13,14]. DCs were long considered to be pro-inflammatory in the mature state and
anti-inflammatory in the immature state [15,16]. Only recently have tolerogenic DCs been
characterized [17–19]. In peripheral tissues, the inflammatory abilities of DC progenitors are
dynamically regulated by the local milieu. Several factors may help imprint DCs tolerance, particularly
in an anatomical compartment exposed to a large variety of antigens [20–22]. In the intestine, incoming
progenitors adapt to the temporary need of the tissue, usually becoming inflammatory-impaired DCs;
nonetheless, traumatic events and/or hostile infections can change the intestinal milieu that may
become inflammatory permissive [23]. DCs polarization in the intestine represents a paradigm for
the induction of tolerogenic DCs—a dynamic imprinting mediated by the host secreted factors [24],
the microbiome [25,26], and nutritionally-derived factors [27].
In the small intestine, DCs can sample luminal antigen by projecting “periscopes” through the
epithelial monolayer into the intestinal lumen [28–31]. Due to the mucus and antimicrobial protein
gradient, the tip of the villi are more frequently exposed to luminal antigens, and consequently, DCs
periscopes are more frequent in this region [29].
We already demonstrated that Slpi is required for quercetin-mediated immune suppression [32].
Quercetin exposure can induce Slpi expression even in the absence of inflammatory insult, but little
is known about the inflammatory pathway regulated by Slpi. Here we further explored the axis
between quercetin-exposed DCs, inflammasome secretion, and Slpi expression. We then addressed if a
quercetin-enriched diet was able to induce Slpi expression along the ileum and colon. Knowing that
DCs extensions into the intestinal lumen were more frequent at the tip of the villi, we investigated
if the presence of quercetin in the lumen could determine a gradient of Slpi expression from the tip
to the base of the villi. Our results indicate that DCs may better sense (and respond to) the intestinal
content if located at the tip of the intestinal villi, highlighting the importance of nutritionally-derived
bioactive compounds in educating the immune response.
2. Materials and Methods
2.1. Mice
Ethics Statement: investigation has been conducted according to national and international
guidelines and has been approved by the authors’ institutional review board (Commission for Animal
Wellbeing—OPBA).
Six-to-eight-week-old male mice were purchased from Jackson Laboratories: Wild-type C57BL/6
(Stock No.: 000664; weight: approximately 20 g) and B6; 129-Slpitm1Smw/J (Stock No.: 010926;
weight: approximately 20 g). C57BL/6 and B6; 129-Slpitm1Smw/J mice were fed with either a
quercetin-enriched food (0.5%) for 4 weeks using aglycone quercetin powder (FARMALABOR SRL Cat
n. 1936) or a standard diet (six mice were used in each group). All animal experiments were carried
out in accordance with Directive 86/609 EEC enforced by Italian D.L. n. 26/2014, and approved by the
Committee on the Ethics of Animal Experiments of Ministero della Salute—Direzione Generale Sanità
Animale (Prot. 2012/00000923 A00: Eo_GINRC and 103/2016-PR) and the official RBM veterinarian.
Animals were euthanatized if found in severe clinical condition in order to avoid undue suffering.
2.2. Generation and Culture of Murine DCs
Bone marrow derived DCs (BMDCs) were obtained from 6–8 week old male C57BL/6 or Slpi-KO mice.
Briefly, a single cell suspension of BMDCs was prepared by flushing the tibiae and femurs with 0.5 mM
EDTA followed by hypotonic lysis of red blood cells with ACK (Ammonium-Chloride-Potassium)
lysing buffer. Cells were plated in a 10 mL dish (1 × 106 cells/mL) and cultured in RPMI 1640
supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/mL penicillin, 100 mg/mL
streptomycin, 25 µg/mL rmGM-CSF and 25 µg/mL rmIL-4 at 37 ◦C in a humidified 5% CO2
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atmosphere. On day 5, cells were harvested, restimulated with new growth factors, and plated
1 × 106 cells/mL on a 24-well culture plate. Cells were treated with 25 µM of quercetin on day 5 and
day 7. On day 8, BMDCs were stimulated with 1 µg/mL of lipopolysaccharide (LPS) for 24 h.
Materials
Cell culture media and antibiotics were obtained from Thermo Fisher Scientific, Waltham, MA,
USA. Growth factors were obtained from Miltenyi Biotec, Bergisch Gladbach, Germany. Quercetin and
LPS (L6143) were obtained from Sigma-Aldrich, St. Louis, MO, USA.
2.3. Multiplex
Cell culture supernatants were analyzed using the Bead-based Multiplex for the Luminex®
platform (LaboSpace srl, Via Ranzato, 12—20128 Milan, Italy).
2.4. Cytofluorimetric Analysis
FoxP3 staining: Spleen, mesenteric lymph nodes (MLNs) and lamina propria (LP) were isolated
from 6-to-8-week old mice fed with standard or quercetin-enriched food. Spleen and MLNs were
passed through a 40 µm cell strainer (BD Biosciences, Franklin Lakes, NJ, USA) to obtain a single
cells suspension that was washed with DPBS 1X (Gibco, NY, USA) + 0.5% bovine serum albumin
(BSA, Sigma-Aldrich, St. Louis, MO, USA). LP T-cell analysis was performed starting from single cell
suspension of the ileum. Briefly, Peyer’s Patches were removed, intestinal segments (1 cm long) were
washed with 2.5 mM EDTA to remove the epithelial cells and digested with collagenase and DNase
(Sigma Aldrich, St. Louis, MO, USA) using the GentleMacs suggested protocol. Single cells suspensions
from spleen, MLNs, and LP were stained with CD4 APC-Vio 700 (Miltenyi Biotec, Bergisch Gladbach,
Germany). Cells were then permeabilized with Foxp3 Fixation/Permeabilization Kit (eBioscience, San
Diego, CA, USA) and subsequently washed with PERM Buffer (eBioscience, San Diego, CA, USA).
Finally, cells were stained with Foxp3 PE-Cy5 (Miltenyi Biotec, Bergisch Gladbach, Germany). Flow
Cytometer acquisition was performed using NAVIOS (Beckman Coulter, Brea, CA, USA).
T cells Intracellular Staining: T cells from spleen, MLN, and LP from 8-week-old mice fed with
standard or quercetin-enriched food were cultured with a 500X Cell Stimulation Cocktail (eBiosceince,
San Diego, CA, USA) for 12 h, washed with DPBS 1X + 0.5% BSA and stained with CD4 APC-Vio
700 (Miltenyi Biotec, Bergisch Gladbach, Germany). After washing, cells were then permeabilized
with BD CytoFix/CytoPerm® Fixation/Permeabilization Kit® (BD Biosciences, Franklin Lakes, NJ,
USA), washed with PERM Buffer, and stained with: IL-17A FITC, IFNγ-APC, TNFα PE and IL-4 APC
as per manufacturer’s instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). Flow Cytometer
acquisition was performed using NAVIOS.
2.5. Laser Capture Microdissection (LCM)
The lamina propria cells from the tip or the base of the ileum were micro-dissected using a
Leica CTR 6000 microscope (Leica Microsystems, Wetzlar, Germany). Tissues were explanted and
immediately embedded in OCT (VWR International, Radnor, PA, USA) and frozen at −80 ◦C. Serial
sections (10 µm) were cut by a cryostat (TiEsseLab, Milan, Italy) and placed on 4 µm PEN Frame slides
(Cod. 11600289, Leica Microsystems, Wetzlar, Germany). Sections were stained with hematoxylin and
eosin (H & E) standard protocol and immediately micro-dissected to collect the mRNA.
2.6. RNA Extraction and Quantitative PCR (qPCR) Analysis
Total RNA was isolated from the ileum and colon. The RNA was extracted using TRIzol® (Thermo
Fisher Scientific, Waltham, MA, USA) according to manufacturer’s instructions. Five hundred ng of
total RNA was reverse transcribed with the High Capacity cDNA Reverse Transcription kit (Thermo
Fisher Scientific, Waltham, MA, USA) by using random primers for cDNA synthesis. Gene expression
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of Slpi and Gapdh were determined by using TaqMan Gene Expression Assays (Thermo Fisher
Scientific, Waltham, MA, USA)—murine probes: Mm00441530_g1 and Mm99999915_g1, respectively.
Real-time analysis performed on CFX96 System (Biorad, Hercules, CA, USA) and the expression of all
target genes were calculated relative to GAPDH expression using ∆∆Ct method.
2.7. Quercetin Quantification from Fecal Samples
Stool and intestinal content samples were thawed, accurately weighed and extracted as follows:
Samples were solubilized in Methanol and subjected to ultrasonic bath for 15 min. Subsequently
samples were centrifuged at 4 ◦C for 15 min the process was repeated three times. Supernatants were
pooled and dried under reduced pressure. All samples were re-solubilized in methanol (1 mL) filtered
on 0.45 µm filters and injected. Homogenized tissue samples with METABOPREP-LC kit (Hosmotic,
Piano di Sorrento (NA), Italy) according to producer instructions. Liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analyses were performed on a Nexera UHPLC coupled to a triple
quadrupole LCMS-8050 (Shimadzu, Milan, Italy). The separation was carried out with a 50 × 2.1 mm,
1.7 µm BEH C18 column (Waters, Milford, MA, USA). Mobile phases were: A) 0.1% CH3COOH in
Water v/v, B) ACN plus 0.1% CH3COOH v/v. Gradient 0–3.00 min, 10–98% B, hold for 30 s, returning
at 10%B in 0.1 s. Column equilibration 2 min. Column oven: 45 ◦C. MS detection was performed
in negative ionization (ESI−) in multiple reaction monitoring (MRM): quantifier 301-151, qualifier
301-179. Interface temperature 400 ◦C, Desolvation line 200 ◦C, Heat Block 400 ◦C. Drying gas (N2)
10 L/min, Heating gas (air) 10 L/min, Nebulizing gas 3 L/min. Probe voltage−3.5 kV, detector voltage
1.80 kV. Quercetin was quantified by external calibration. A stock solution of quercetin 1 mg/1 mL was
prepared in methanol and a seven point calibration curve was built (0.025–70 µg/mL) and triplicate
analyses of each point were run; this methodology showed excellent linearity (R2: 0.999). Quercetin
quantification refers to stool samples and intestinal content collected from duodenum, ileum, and
colon of mice fed for 28 days with quercetin-enriched food as compared to mice fed with standard
food. Additionally, the ileum content was assessed for quercetin levels. For this analysis, the tissue
was collected in dH2O and homogenized with GentleMACS® (Miltenyi Biotec, Bergisch Gladbach,
Germany) by using the program for protein digestion specific for M tubes® (Miltenyi Biotec, Bergisch
Gladbach, Germany).
2.8. Statistical Analysis
Statistical analysis was performed using the Graphpad Prism statistical software release 5.0
for Windows XP. All data were expressed as means ± SEM of data obtained from at least three
independent experiments. We evaluated the statistical significance of the grouped analysis with
the two-way ANOVA test using the Bonferroni as a post-test. Results were considered statistically
significant at p < 0.05.
3. Results and Discussion
3.1. Quercetin Fails to Reduce Inflammatory Cytokine Secretion in Slpi-KO DCs
We recently demonstrated that quercetin-exposed DCs from wild-type (WT) mice reduce their
ability to release tumor necrosis factor alpha (TNFα), interleukin 1 alpha, 1 beta, 6, 10 and 12 (IL-1α,
IL-1β, IL-6, IL-10, and IL-12) following LPS administration [10,11] and that Slpi expression was a
non-redundant checkpoint required for quercetin-mediated TNFα secretion suppression [32]. Here
we explored the secretion of IL-1α, IL-1β, IL-6, IL-10, and IL-12 from quercetin-exposed Slpi-KO
DCs following LPS administration. Slpi-KO DCs respond to LPS by releasing higher amounts of
TNFα, IL-1α, IL-1β, and IL-12. However, quercetin administration failed to reduce inflammatory
cytokine secretion in Slpi-KO DCs (Figure 1), which was in contrast to previously observed effects on
WT DCs [10,11]. Notably, LPS-induced IL-1β secretion from Slpi-KO DCs was increased following
pre-exposure to quercetin (Figure 1). Altogether, these analyses of the secretome confirm the role of
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quercetin as an anti-inflammatory agent [32], and provide a new insight into how quercetin can exert its
effects on IL-1β secretion in the absence of Slpi. The anti-inflammatory effects of quercetin were absent
or reduced in the absence of Slpi for all cytokines considered, with the exception of IL-1β, suggesting a
different regulatory machinery involved in the secretion of this crucial inflammatory cytokine.
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was significantly higher in LPS-treated Slpi-KO DCs pre-exposed to quercetin. Strikingly, Slpi-KO 
DCs failed to release CXCL-1 in response to LPS administration, independent of quercetin exposure 
(Figure 2). CXCL-1 is a major neutrophil chemoattractant and binds to CXCR2 in mice [33]. This 
novel observation may be important for future investigation due to the crucial role of CXCL-1 in 
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Figure 1. Quercetin reduces inflammatory cytokines secretion in wild-type (WT) dendritic cells (DCs).
Bone marrow-derived DCs (BMDCs) were cultured from WT (black bars) and Slpi-KO (white bars) mice,
treated with quercetin at day 5 and 7 and exposed to lipopolysaccharide (LPS). Secretion of cytokines
was determined 24 h later by Multiplex assay. Bars represent mean concentration of interleukin-6 (IL-6),
tumor necrosis factor alpha (TNFα), interleukin-10 (IL-10), interleukin-12 (IL-12), interleukin-1 alpha
(IL-1α) and interleukin-1 beta (IL-1β) ± SEM (n = 4). *** p < 0.001, ** p < 0.01.
3.2. Slpi-KO DCs Fail to Secrete CXCL-1 Independently from Quercetin Exposure
The chemokine secretion profile was differentially modulated in WT and Slpi-KO DCs. Slpi-KO
cells released higher amounts of CCL-2, CCL-3, and CCL-4 following 24 h LPS stimulation compared
to DCs from WT mice. However, quercetin pre-exposure did not affect the secretion of CCL-2, CCL-3,
CCL-4, or CCL-11. Of note (and different from other chemokines), CCL-5 secretion was significantly
higher in LPS-treated Slpi-KO DCs pre-exposed to quercetin. Strikingly, Slpi-KO DCs failed to release
CXCL-1 in response to LPS administration, independent of quercetin exposure (Figure 2). CXCL-1 is a
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major neutrophil chemoattractant and binds to CXCR2 in mice [33]. This novel observation may be
important for future investigation due to the crucial role of CXCL-1 in neutrophil recruitment.
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diet to wild-type mice. Mice received quercetin-enriched or standard diet for 4 weeks. No difference 
in food consumption or mice weight was registered (data not shown). To evaluate the quantity of 
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colon, and mice stools following 4 weeks of enriched-diet and assessed quercetin presence by LC-MS 
analyses. We also collected 0.5 cm of the ileum and quantified quercetin present in the cellular 
extract. Quercetin concentration was higher in the duodenum and gradually diminished passing 
from the ileum to the colon (Table 1). These data confirm that quercetin was able to safely pass the 
stomach and reach the intestinal lumen. Quercetin was detected at a very low concentration in cell 
extract from the ileum, suggesting local rather than systemic DCs exposure to quercetin in these 
Figure 2. Quercetin exposure and chemokines release. Slpi-KO DCs fail to release the chemokine
(C-X-C motif) ligand-1 CXCL-1 following LPS administration independent y from quercetin exp sur .
BMD s were cu ture from WT (black bars) and Slpi-KO (white bars) mice, treated with quercetin at
day 5 and 7 and exposed to LPS. Secretion of chemokines was determined aft r 24 h by Multipl x assay.
Bars r present mean concentrati n of he (C-C motif) ligand-2, -3, -4, -5, -11 (CCL-2, CCL-3, CCL-4,
CCL-5, CCL-11) and CXCL-1 ± SEM (n = 4). *** p < 0.001, ** p < 0.01.
3.3. A Quercetin-Enriched Diet Promotes Slpi Expression in the Ileum and Colon
We already demonstrated that quercetin was able to induce Slpi expression in murine colon
if administered by gavage [32]. Quercetin is commonly present in fruits and vegetables; thus, we
decided to evaluate whether Slpi expression could be induced by providing a quercetin-enriched diet
to wild-type mice. Mice received quercetin-enriched or standard diet for 4 weeks. No difference in food
consumption or mice weight was registered (data not shown). To evaluate the quantity of quercetin
present in the intestinal lumen, we collected the luminal content of the duodenum, ileum, colon, and
mice stools following 4 weeks of enriched-diet and assessed quercetin presence by LC-MS analyses.
We also collected 0.5 cm of the ileum and quantified quercetin present in the cellular extract. Quercetin
concentration was higher in the duodenum and gradually diminished passing from the ileum to the
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colon (Table 1). These data confirm that quercetin was able to safely pass the stomach and reach the
intestinal lumen. Quercetin was detected at a very low concentration in cell extract from the ileum,
suggesting local rather than systemic DCs exposure to quercetin in these experimental conditions.
Although not direct evidence of quercetin absorption (serum levels of quercetin were below detection
in line with what has previously been demonstrated [34]), the following results showing Slpi induction
are consistent with at least some of the ingested quercetin being able to induce biological effects in
the host.
Table 1. Quantification of quercetin in stool samples from different regions of the intestine obtained
by liquid chromatography-mass spectrometry (LC-MS). Mean values for mice fed with standard and
quercetin-enriched food are expressed in µg/mL for fecal sample and ng/10 mg for ileum tissue.
Sample Analysis Standard Food (µg/mL) Quercetin-Enriched Food (µg/mL)
Stool Not Detected 696.47 ± 600.13
Duodenum content Not Detected 108.44 ± 106.18
Ileum content Not Detected 76.44 ± 54.21
Colon content Not Detected 49.43 ± 0.46
Ileum tissue Not Detected 0.26 ± 0.21
Slpi expression was assessed by qPCR in the duodenum, ileum, and colon. A quercetin-enriched
diet induced Slpi expression in the ileum and colon, but failed to induce Slpi in the duodenum
(Figure 3). These results suggest that Slpi induction was the result of local rather than systemic DCs
exposure to quercetin. To investigate if quercetin-enriched food could change the T cell polarization,
we performed the intracellular staining of spleen, MLNs, and LP CD4+ T cells. Figure 4 shows that
no significant difference was detected in the TNFα, IFNγ, and Foxp3 populations, likely due to the
absence of an inflammatory insult. Additionally, IL-17A and IL-4 CD4+ T cells percentages did not
change with the quercetin-enriched diet (data not shown).
Slpi induction observed in the absence of inflammation supports the idea of polyphenol-rich
nutritional regimes that may help to prevent chronic inflammatory syndromes.
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Figure 3. Quercetin induces Slpi expression in the ileum and colon. Quercetin-enriched or standard diet
was administered for 4 weeks. Slpi expression was measured by qPCR in the small intestine or colon
of standard (black bars) and quercetin (white bars) fed mice. Bars represent mean expression ± SEM
(n = 3) for each treatment. *** p < 0.001, * p < 0.05.
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Figure 4. T cell polarization in mesenteric lymph node (MLN), spleen, and lamina propria (LP).
Representative intracellular staining of CD4+ T cells. No significant differences could be observed in
the percentage of TNFα+, IFNγ+, or Foxp3+ cells in mice treated with standard or quercetin-enriched
diet (n = 3).
3.4. Quercetin-Mediated Slpi Induction Is Detectable at the Tip of the Villi
In healthy individuals, the mucosal immune system is dynamically educated towards tolerance
to luminal antigens, including commensal bacteria and food derived antigens [35]. Several factors
contribute to DCs’ “maturation” [23,24], including food-derived products [27]. Intestinal dendritic cells
resident in the lamina propria of the villi are able to project periscope-like dendrites into the intestinal
lumen and sample luminal content [28–30]. As the periscope distribution is mainly concentrated at
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the tip of the villi, we aimed to detect a correlation between Slpi expression and DCs localization
along the villus axis. (Figure 5A). Slpi mRNA expression was increased in samples taken from the
tip of the villi in mice fed a quercetin-rich diet (Figure 5B). We acknowledge that this is an indirect
indication that sampling DCs encounter quercetin directly in the intestinal lumen and respond to it by
up-regulating Slpi. However, it is conceivable that nutritionally-derived factors contribute directly
to the intestinal immune cell response by inducing the expression of proteins capable of attenuating
the inflammatory response. Indeed, Slpi is also induced by the thymic stromal lymphopoetin
(Tslp) [36]—a key factor for intestinal dendritic cell “maturation” [37]. Future studies will further
elucidate how nutritional compounds can be used to modulate immune tolerance and mucosal
homeostasis through the Slpi–DCs axis, paving the way for the translational use of Slpi-inducing diets
for chronic inflammatory syndromes.
Nutrients 2017, 9, 706 9 of 11 
 
localization along the villus axis. (Figure 5A). Slpi mRNA expression was increased in samples taken 
from the tip of the villi in mice fed a quercetin-rich diet (Figure 5B). We acknowledge that this is an 
indirect indication that sampling DCs encounter quercetin directly in the intestinal lumen and 
respond to it by up-regulating Slpi. However, it is conceivable that nutritionally-derived factors 
contribute directly to the intestinal immune cell response by inducing the expression of proteins 
capable of attenuating the inflammatory response. Indeed, Slpi is also induced by the thymic stromal 
lymphopoetin (Tslp) [36]—a key factor for intestinal dendritic cell “maturation” [37]. Future studies 
will further elucidate how nutritional compounds can be used to odulate immune tolerance and 
mucosal homeostasis through the Slpi–DCs axis, paving the way for the translational use of 
Slpi-inducing diets for chronic inflammatory syndromes. 
 
Figure 5. Quercetin induces Slpi expression in the tip of the intestinal villi. Animals were 
administered quercetin-enriched or standard diet for 4 weeks. (A) Representative image 
demonstrating captured lamina propria cells from the tip (red) or the base (green) of intestinal villi; 
(B) Lamina propria cells from standard (black bars) and quercetin (white bars) diet were 
laser-captured and Slpi expression measured by qPCR. Bars represent mean expression ± SEM (n = 3) 
for each treatment. *** p < 0.001. 
4. Conclusions 
Nutritional regimes enriched in quercetin may create a pro-tolerogenic milieu in the 
gastrointestinal tract, which could help maintain homeostasis and prevent chronic inflammatory 
disorders. This work suggests that antigen presenting cells (DCs) residing at the tip of the intestinal 
villi project dendrites into a quercetin-rich intestinal lumen and subsequently upregulate Slpi 
expression. Slpi+ DCs are able to suppress the inflammatory cascade even in the presence of LPS, 
while Slpi-KO DCs fail to respond to quercetin and release high amounts of inflammatory cytokines. 
Our data indicate that nutritionally-derived quercetin is able to imprint Slpi expression in DCs 
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response of the lamina propria-resident dendritic cells to luminal quercetin, rather than the systemic 
effects. Additional studies are required to prove nutritional regimes enriched in quercetin can be 
considered important to sustain intestinal homeostasis and immunological tolerance in an 
Slpi-dependent manner. 
Acknowledgments: This work was supported by the Italian Ministry of Health, “GR-2011-02347991”, TomGEM 
European Union’s Horizon 2020 research and innovation programme under grant agreement No. 679796 and 
by Regione Puglia “NATURE–XUANRO4”. We are grateful to all members of LAB-81 and to the I.C. Bregante 
Volta of Monopoli (BA) for their constructive help and support. 
Author Contributions: M.C., M.N. and A.S. conceived and designed the experiments; S.D.S., V.G., L.S. and E.S. 
performed the experiments; A.S., A.P., S.D.S., G.S. and P.C. analyzed the data; M.L. and V.S. contributed 
reagents/materials/analysis tools; M.C. and S.D.S. wrote the paper.  
Conflicts of Interest: The authors declare no financial or commercial conflict of interest. 
i r 5. Quercetin i duces Slpi expression in the tip of the intestinal villi. Animals were ad inister d
quercetin-enriched or standard diet for 4 weeks. (A) Representativ image demonstrating captured
lamina p opria ells f om the tip ( ed) or the base (gr en) of intestinal villi; B) Lamina propria ce s
from stand rd (black bars) and quercetin (white bars) diet were las r-captured and Slpi expression
measured by qPCR. Bars repre ent n expression ± SEM (n = 3) for each treatment. *** p < 0.001.
4. Conclusions
Nutritional regimes enriched in quercetin may create a pro-tolerogenic milieu in the
gastrointestinal tract, which could help maintain homeostasis and prevent chronic inflammatory
disorders. This work suggests that antigen presenting cells (DCs) residing at the tip of the intestinal villi
project dendrites into a quercetin-rich intestinal lumen and subsequently upregulate Slpi expression.
Slpi+ DCs are able to suppress the inflammatory cascade even in the presence of LPS, while Slpi-KO
DCs fail to respond to quercetin and release high a ounts of inflammatory cytokines. Our data
indicate that nutritionally-derived quercetin is able to imprint Slpi expression in DCs resident in the
tip of the intestinal villi, where the frequency of DC protrusions into the intestinal lumen is far greater.
It is important to underline that results obtained within this study address the response of the lamina
propria-resident dendritic cells to luminal quercetin, rather than the systemic effects. Additional
studies are required to prove nutritional regimes enriched in quercetin can be considered important to
sustain intestinal homeostasis and immunological tolerance in an Slpi-dependent manner.
Acknowledgments: This work was supported by the Italian Ministry of Health, “GR-2011-02347991”, TomGEM
European Union’s Horizon 2020 research and innovation programme under grant agreement No. 679796 and by
Regione Puglia “NATURE–XUANRO4”. We are grateful to all members of LAB-81 and to the I.C. Bregante Volta
of Monopoli (BA) for their constructive help and support.
Author Contributions: M.C., M.N. and A.S. conceived and designed the experiments; S.D.S., V.G., L.S. and
E.S. performed the experiments; A.S., A.P., S.D.S., G.S. and P.C. analyzed the data; M.L. and V.S. contributed
reagents/materials/analysis tools; M.C. and S.D.S. wrote the paper.
Conflicts of Interest: The authors declare no financial or commercial conflict of interest.
Nutrients 2017, 9, 706 10 of 11
References
1. David, A.V.A.; Arulmoli, R.; Parasuraman, S. Overviews of Biological Importance of Quercetin: A Bioactive
Flavonoid. Pharmacogn. Rev. 2016, 10, 84–89. [CrossRef]
2. Kelsey, N.A.; Wilkins, H.M.; Linseman, D.A. Nutraceutical antioxidants as novel neuroprotective agents.
Molecules 2010, 15, 7792–7814. [CrossRef] [PubMed]
3. Jovanovic, S.V.; Simic, M.G. Antioxidants in nutrition. Ann. N. Y. Acad. Sci. 2000, 899, 326–334. [CrossRef]
[PubMed]
4. Niedzwiecki, A.; Roomi, M.W.; Kalinovsky, T.; Rath, M. Anticancer Efficacy of Polyphenols and Their
Combinations. Nutrients 2016, 8, 552. [CrossRef] [PubMed]
5. Harris, Z.; Donovan, M.G.; Branco, G.M.; Limesand, K.H.; Burd, R. Quercetin as an Emerging Anti-Melanoma
Agent: A Four-Focus Area Therapeutic Development Strategy. Front. Nutr. 2016, 3, 48. [CrossRef] [PubMed]
6. Refolo, M.G.; D’Alessandro, R.; Malerba, N.; Laezza, C.; Bifulco, M.; Messa, C.; Caruso, M.G.; Notarnicola, M.;
Tutino, V. Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor
in Human Colon Cancer Cell Lines. J. Cell. Physiol. 2015, 230, 2973–2980. [CrossRef] [PubMed]
7. Xue, F.; Nie, X.; Shi, J.; Liu, Q.; Wang, Z.; Li, X.; Zhou, J.; Su, J.; Xue, M.; Chen, W.D.; et al. Quercetin Inhibits
LPS-Induced Inflammation and ox-LDL-Induced Lipid Deposition. Front. Pharmacol. 2017, 8, 40. [CrossRef]
[PubMed]
8. Li, Y.; Yao, J.; Han, C.; Yang, J.; Chaudhry, M.T.; Wang, S.; Liu, H.; Yin, Y. Quercetin, Inflammation and
Immunity. Nutrients 2016, 8, 167. [CrossRef] [PubMed]
9. Boots, A.W.; Wilms, L.C.; Swennen, E.L.; Kleinjans, J.C.; Bast, A.; Haenen, G.R. In vitro and ex vivo
anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 2008, 24, 703–710. [CrossRef]
[PubMed]
10. Cavalcanti, E.; Vadrucci, E.; Delvecchio, F.R.; Addabbo, F.; Bettini, S.; Liou, R.; Monsurrò, V.; Huang, A.Y.;
Pizarro, T.T.; Santino, A.; et al. Administration of reconstituted polyphenol oil bodies efficiently suppresses
dendritic cell inflammatory pathways and acute intestinal inflammation. PLoS ONE 2014, 9, e88898.
[CrossRef] [PubMed]
11. Delvecchio, F.R.; Vadrucci, E.; Cavalcanti, E.; De Santis, S.; Kunde, D.; Vacca, M.; Myers, J.; Allen, F.;
Bianco, G.; Huang, A.Y.; et al. Polyphenol administration impairs T-cell proliferation by imprinting a distinct
dendritic cell maturational profile. Eur. J. Immunol. 2015, 45, 2638–2649. [CrossRef] [PubMed]
12. Galleggiante, V.; De Santis, S.; Cavalcanti, E.; Scarano, A.; De Benedictis, M.; Serino, G.; Caruso, M.L.;
Mastronardi, M.; Pinto, A.; Campiglia, P.; et al. Dendritic Cells Modulate Iron Homeostasis and Inflammatory
Abilities Following Quercetin Exposure. Curr. Pharm. Des. 2017, 23, 2139–2146. [CrossRef]
13. Banchereau, J.; Steinman, R.M. Dendritic cells and the control of immunity. Nature 1998, 392, 245–252.
[CrossRef] [PubMed]
14. Stoll, S.; Delon, J.; Brotz, T.M.; Germain, R.N. Dynamic imaging of T cell-dendritic cell interactions in lymph
nodes. Science 2002, 296, 1873–1876. [CrossRef] [PubMed]
15. Lutz, M.B.; Schuler, G. Immature, semi-mature and fully mature dendritic cells: Which signals induce
tolerance or immunity? Trends Immunol. 2002, 23, 445–449. [CrossRef]
16. Mahnke, K.; Schmitt, E.; Bonifaz, L.; Enk, A.H.; Jonuleit, H. Immature, but not inactive: The tolerogenic
function of immature dendritic cells. Immunol. Cell Biol. 2002, 80, 477–483. [CrossRef] [PubMed]
17. Sim, W.J.; Malinarich, F.; Fairhurst, A.M.; Connolly, J.E. Generation of Immature, Mature and Tolerogenic
Dendritic Cells with Differing Metabolic Phenotypes. J. Vis. Exp. 2016. [CrossRef] [PubMed]
18. Raker, V.K.; Domogalla, M.P.; Steinbrink, K. Tolerogenic Dendritic Cells for Regulatory T Cell Induction in
Man. Front. Immunol. 2015, 6, 569. [CrossRef] [PubMed]
19. Longoni, D.; Piemonti, L.; Bernasconi, S.; Mantovani, A.; Allavena, P. Interleukin-10 increases mannose
receptor expression and endocytic activity in monocyte-derived dendritic cells. Int. J. Clin. Lab. Res. 1998, 28,
162–169. [CrossRef] [PubMed]
20. Schmidt, S.V.; Nino-Castro, A.C.; Schultze, J.L. Regulatory dendritic cells: There is more than just immune
activation. Front. Immunol. 2012, 3, 274. [CrossRef] [PubMed]
21. Naik, S.; Bouladoux, N.; Linehan, J.L.; Han, S.J.; Harrison, O.J.; Wilhelm, C.; Conlan, S.; Himmelfarb, S.;
Byrd, A.L.; Deming, C.; et al. Commensal-dendritic-cell interaction specifies a unique protective skin
immune signature. Nature 2015, 520, 104–108. [CrossRef] [PubMed]
Nutrients 2017, 9, 706 11 of 11
22. Eri, R.; Chieppa, M. Messages from the Inside. The Dynamic Environment that Favors Intestinal Homeostasis.
Front. Immunol. 2013, 4, 323. [CrossRef] [PubMed]
23. Rescigno, M.; Chieppa, M. Gut-level decisions in peace and war. Nat. Med. 2005, 11, 254–255. [CrossRef]
[PubMed]
24. Rescigno, M.; Lopatin, U.; Chieppa, M. Interactions among dendritic cells, macrophages, and epithelial cells
in the gut: Implications for immune tolerance. Curr. Opin. Immunol. 2008, 20, 669–675. [CrossRef] [PubMed]
25. Thaiss, C.A.; Zmora, N.; Levy, M.; Elinav, E. The microbiome and innate immunity. Nature 2016, 535, 65–74.
[CrossRef] [PubMed]
26. Belkaid, Y.; Hand, T.W. Role of the microbiota in immunity and inflammation. Cell 2014, 157, 121–141.
[CrossRef] [PubMed]
27. De Santis, S.; Cavalcanti, E.; Mastronardi, M.; Jirillo, E.; Chieppa, M. Nutritional Keys for Intestinal Barrier
Modulation. Front. Immunol. 2015, 6, 612. [CrossRef] [PubMed]
28. Rescigno, M.; Urbano, M.; Valzasina, B.; Francolini, M.; Rotta, G.; Bonasio, R.; Granucci, F.; Kraehenbuhl, J.P.;
Ricciardi-Castagnoli, P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers
to sample bacteria. Nat. Immunol. 2001, 2, 361–367. [CrossRef] [PubMed]
29. Niess, J.H.; Brand, S.; Gu, X.; Landsman, L.; Jung, S.; McCormick, B.A.; Vyas, J.M.; Boes, M.; Ploegh, H.L.;
Fox, J.G.; et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science
2005, 307, 254–258. [CrossRef] [PubMed]
30. Chieppa, M.; Rescigno, M.; Huang, A.Y.; Germain, R.N. Dynamic imaging of dendritic cell extension into
the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 2006, 203, 2841–2852.
[CrossRef] [PubMed]
31. Mazzini, E.; Massimiliano, L.; Penna, G.; Rescigno, M. Oral tolerance can be established via gap junction
transfer of fed antigens from CX3CR1+ macrophages to CD103+ dendritic cells. Immunity 2014, 40, 248–261.
[CrossRef] [PubMed]
32. De Santis, S.; Kunde, D.; Serino, G.; Galleggiante, V.; Caruso, M.L.; Mastronardi, M.; Cavalcanti, E.;
Ranson, N.; Pinto, A.; Campiglia, P.; et al. Secretory leukoprotease inhibitor is required for efficient
quercetin-mediated suppression of TNFα secretion. Oncotarget 2016, 7, 75800–75809. [CrossRef] [PubMed]
33. Lida, N.; Grotendorst, G.R. Cloning and sequencing of a new gro transcript from activated human monocytes:
Expression in leukocytes and wound tissue. Mol. Cell. Biol. 1990, 10, 5596–5599.
34. Riches, A.C.; Sharp, J.G.; Thomas, D.B.; Smith, S.V. Blood volume determination in the mouse. J. Physiol.
1973, 228, 279–284. [CrossRef] [PubMed]
35. Santino, A.; Scarano, A.; Santis, S.; Benedictis, M.; Giovinazzo, G.; Chieppa, M. Gut microbiota modulation
and anti-inflammatory properties of dietary polyphenols in IBD: New and consolidated perspectives.
Curr. Pharm. Des. 2017. [CrossRef] [PubMed]
36. Reardon, C.; Lechmann, M.; Brüstle, A.; Gareau, M.G.; Shuman, N.; Philpott, D.; Ziegler, S.F.; Mak, T.W.
Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates
recovery from colonic inflammation. Immunity 2011, 35, 223–235. [CrossRef] [PubMed]
37. Rimoldi, M.; Chieppa, M.; Salucci, V.; Avogadri, F.; Sonzogni, A.; Sampietro, G.M.; Nespoli, A.; Viale, G.;
Allavena, P.; Rescigno, M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial
cells and dendritic cells. Nat. Immunol. 2005, 6, 507–514. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
